Announcements Trials
Browse Landscape

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Plasma cell 1Other hematologic neoplasm 1Lymphoid 1

Conditions

Brain Neoplasms 2Neoplasm Metastasis 1Multiple Myeloma 1Lymphoma 1Leukemia 1Hematologic Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Breast Neoplasms, Male 1Breast Neoplasms 1

Interventions

Dexamethasone 64Lenalidomide 37daratumumab 34pomalidomide 31Bortezomib 31Specimen Handling 25carfilzomib 23Biopsy 23Cyclophosphamide 21Magnetic Resonance Spectroscopy 18Calcium Dobesilate 18isatuximab 14fludarabine 12dexamethasone acetate 11dexamethasone 21-phosphate 11auricularum 11talquetamab 10iberdomide 10belantamab mafodotin 10selinexor 8Melphalan 8tocilizumab 7X-Rays 7fludarabine phosphate 6elotuzumab 6Nuclear Medicine Department, Hospital 5trametinib 4pembrolizumab 4nirogacestat 4Sirolimus 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Multiple Myeloma × Mental Status and Dementia Tests × 30 days × Clear all
NCT05011045 2026-05-20

Neurocognitive Outcomes After Whole Brain Radiation Therapy for Hematologic Malignancies

M.D. Anderson Cancer Center

Recruiting
100 enrolled
LymphoidOther hematologic neoplasmPlasma cell

Leukemia, Lymphoma, Multiple Myeloma, Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡